Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001871604-21-000004

Options or other derivatives

  • VP Corporate Controller acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Maranian Jeffrey R · VP Corporate Controller

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-12-15 Grant or award : show line 1 in the form Stock Option (right to buy) +15,000 15,000 D
Loading xslF345X03/wf-form4_163977535437475.xml…